Myelofibrosis (MF) Treatment Market

Future Market Insights

Key Insight

The myelofibrosis (mf) treatment market is projected to grow from USD 833.7 million in 2025 to USD 1,424.1 million by 2035, at a CAGR of 5.5%. Targeted Therapy will dominate with a 66.3% market share, while oral will lead the route of administration segment with a 57.8% share.

August 23, 2025

Anurag Sharma

290 Pages

Cite this Report

Myelofibrosis (MF) Treatment Market

https://www.futuremarketinsights.com/reports/myelofibrosis-mf-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Bayer
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb
F. Hoffmann-La Roche Ag
Fresenius Kabi AG
GSK plc
Hikma Pharmaceuticals PLC
The Vanguard Group
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Myelofibrosis (MF) Treatment Market

Key Players

Similar Industry Reports